BEIJING, June 16 (Reuters) – Novo Nordisk plans to seek Chinese regulatory approval for its Wegovy weight-loss pill "very soon," its CEO said on Tuesday, as it moves to catch up with rival Eli Lilly
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Veon raises outlook, flags digital investments in Ukraine
By Gianluca Lo Nostro July 31 (Reuters) - Veon, the parent company of Ukraine's leading…
Nasdaq set to open higher as Amazon surge offsets Apple decline
By Johann M Cherian and Ragini Mathur July 31 (Reuters) - The Nasdaq was set…
UK finance minister says FIFA's World Cup sale plan is collapsing
VIDEO SHOWS: BRITAIN'S FINANCE MINISTER JOHN HEALEY SPEAKING ABOUT FIFA'S PLANS TO SELL A STAKE…
